654 Results

People

  1. Motzer
    Motzer
  2. Mulhall
    Mulhall
  3. Saltz
    Saltz
  4. Hudis
    Hudis
  5. Abou-Alfa
    Abou-Alfa
  6. Lichtman
    Lichtman
  7. De Angelis
    De Angelis
  8. Ginsberg
    Ginsberg
  9. Russo
    Russo
  10. Feldman
    Feldman

Groups

  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)
  7. Division of Subspecialty Medicine (78)
  8. Center for Hematologic Malignancies (77)
  9. Epidemiology and Biostatistics (69)
  10. Radiology, Department of (61)
  1. "hypertension"
Formats
  1. Journal Article (607)
  2. Review (31)
  3. Editorial (6)
  4. Guidelines (4)
  5. Research Letter (3)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)

More Groups

People
  1. Robert Motzer (59)
  2. John Mulhall (21)
  3. Leonard Saltz (18)
  4. Clifford Hudis (16)
  5. Richard Steingart (14)
  6. Ghassan Abou-Alfa (13)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (31)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Clinical Cancer Research (20)
  3. Lancet Oncology (20)
  4. Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. Journal of Sexual Medicine (14)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Elsevier Science, Inc. (58)
  3. Springer (47)
  4. American Society of Clinical Oncology (42)
  5. Oxford University Press (39)
  6. Wiley Blackwell (35)

More Publishers

Results (654)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): Post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Bendamustine with dexamethasone in relapsed/ refractory systemic light-chain amyloidosis: Results of a phase II study
    Journal Article

    Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Osman, K.; Pan, S.; Bhutani, D.; Pregja, S.; Sanchorawala, V.; Landau, H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
    Journal Article

    Schroeder, M. A.; Jean Khoury, H.; Jagasia, M.; Ali, H.; Schiller, G. J.; Staser, K.; Choi, J.; Gehrs, L.; Arbushites, M. C.; Yan, Y.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia
    Journal Article

    Shah, N. N.; Bhojwani, D.; August, K.; Baruchel, A.; Bertrand, Y.; Boklan, J.; Dalla-Pozza, L.; Dennis, R.; Hijiya, N.; Locatelli, F.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Bother associated with climacturia after radical prostatectomy: Prevalence and predictors
    Journal Article

    Salter, C. A.; Bach, P. V.; Miranda, E.; Jenkins, L. C.; Benfante, N.; Schofield, E.; Nelson, C. J.; Mulhall, J. P.
    Journal of Sexual Medicine (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Phase I study of trifluridine/tipiracil plus irinotecan and bevacizumab in advanced gastrointestinal tumors
    Journal Article

    Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Makris, L.; Hamada, K.; Berlin, J. D.; Saltz, L. B.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Acalabrutinib and its therapeutic potential in the treatment of chronic lymphocytic leukemia: A short review on emerging data
    Review

    Isaac, K.; Mato, A. R.
    Cancer Management and Research (2020)

    Fulltext@MSK | Save
  • Renal toxicity of systemic therapy for renal cell carcinoma
    Review

    Jaimes, E. A.
    Seminars in Nephrology (2020)

    Fulltext@MSK | Save